New River Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsNew River Pharmaceuticals

New River Pharmaceuticals(NRPH)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Doxepin	Doxepin	1982-01-01	2027-2030	Atopic dermatitis , Pruritus , Pain , Anxiety disorders , Psychotic affective disorders , Depressive disorder
Proferdex	Ferric oxyhydroxide	1982-01-01	2028-2034	—
Triavil	Amitriptyline, Perphenazine	1982-01-01		Pain , Psychotic affective disorders , Depressive disorder , Substance withdrawal syndrome , Vomiting , Nausea , Torticollis , Tourette syndrome , Huntington disease , Schizophrenia , Psychotic disorders , Reye syndrome , Alcohol withdrawal delirium , Anxiety disorders

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Lisdexamfetamine

substance-related disorders

,

amphetamine-related disorders

,

,

attention deficit disorder with hyperactivity

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use